Simon’s ambition is to improve outcomes for frail older people by embedding evidence based medicine into clinical practice (‘campus to clinic’ translational research). His research addresses different models of care for frail older people, assessing feasibility as well as clinical and cost-effectiveness. His educational activities take an interdisciplinary perspective on developing and teaching knowledge locally (frailty services), nationally (BGS) and internationally (EUGMS & EAMA). Implementation of research findings into clinical practice is key, and best exemplified by work on the Silver Book and the Acute Frailty Network.
Dr. Judy Hung is the Director of Echocardiography at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School, Boston, MA. She is Vice President of the American Society of Echocardiography. Her clinical and research focus is on valvular heart disease and applying echocardiographic tools to examine mechanisms of valvular heart disease.
Kristen Schaefer, MD, is a clinician and teacher with extensive experience teaching both specialty and generalist palliative care at Harvard Medical School. Her current research includes a national survey to measure cardiology fellows’ training in palliative and end-of-life care, and a randomized controlled trial of a social work-led outpatient advance care planning intervention for recently hospitalized patients with heart failure. Dr. Schaefer is board certified in Internal Medicine, and Hospice and Palliative Medicine, and was recently named a Fellow of the American Academy of Hospice and Palliative Medicine.
Cardiologist and electrophysiologist with a special interest in CRT, lead extractions, AF and VT ablation. After working in Stockholm, London and Uppsala I am now the director of device surgery and arrhythmia services at the Cardiology department at Skåne University Hospital in Lund, Sweden. Lund is a national referral centre for heart transplantation, children with heart diseases and GUCH-patients and has the largest device implant volumes in Sweden, which means see challenging CRT patients frequently and have to explore new technologies.
Pál Maurovich-Horvat MD PhD MPH, Associate Professor of Cardiology and Radiology, director of the Cardiovascular Imaging Research Group at the Heart and Vascular Center, Semmelweis University and board member of the European Association of Cardiovascular Imaging of the European Society of Cardiology. Dr. Maurovich-Horvat graduated from the Semmelweis University in 2006, and studied clinical effectiveness at the Harvard University, School of Public Health, where he graduated in 2012. His research interest focuses on the development of non-invasive diagnostic imaging strategies to improve personalised cardiovascular risk assessment to identify patients prone to suffer myocardial infarction.